[Event report] Fifth session of the Diet Study Group on Dementia (June 26, 2018)
date : 7/18/2018
Tags: Dementia, Diet Member Briefing
![[Event report] Fifth session of the Diet Study Group on Dementia (June 26, 2018)](https://hgpi.org/en/wp-content/uploads/sites/2/20180626_163423-5.jpg)
The non-partisan Diet Study Group on Dementia headed by House of Representatives member Hayato Suzuki held its fifth session. HGPI is currently providing planning and operations support for this study group. Mr. Takayuki Maeda spoke about an innovative daycare center that he runs for people with dementia called “DAYS BLG!” The center is based on the concept that people involved with the center should come to understand the disease as if they themselves were afflicted with it.
Background
The number of people living with dementia in Japan is expected to rise alongside the aging of the population. Policies to deal with this challenge are urgently needed. Japan has taken up the challenge of such polices by launching the “New Orange Plan” – a comprehensive strategy to address dementia. However, additional measures on dementia will be needed in the future. To that end, a number of House of Representatives members have formed this voluntary, regular, non-partisan study group to encourage as many House of Representatives members as possible to become interested in this issue and knowledgeable about it.
Session presentations
“What I myself had dementia?”
Mr. Takayuki Maeda (Psychiatric Social Workers, President of “Let’s make Machida an open town” NPO; Member of the board of directors of Young onset dementia support center NPO; Member of the advisory board of Dementia friendship club NPO; Member of the board of directors of Japan dementia working group general incorporated association)
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)